Night shift work and the risk of endometrial cancer

被引:235
作者
Viswanathan, Akija N.
Hankinson, Susan E.
Schernhammer, Eva S.
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] KFJ Spital, Ludwig Boltzmann Inst Appl Canc, Vienna, Austria
[6] Appl Canc Res Inst Translat Res Vienna, Vienna, Austria
关键词
D O I
10.1158/0008-5472.CAN-07-2485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Melatonin has several oncostatic properties, including possible anti-estrogenic and anti-aromatase activity, and seems to be linked with fat metabolism. Night workers have lower levels of melatonin, which may predispose them to develop cancer. Endometrial cancer risk is influenced significantly by hormonal and metabolic factors; therefore, we hypothesize that night workers may have an increased risk of endometrial cancer. Of the 121,701 women enrolled in a prospective cohort study, 53,487 women provided data on rotating night shift work in 1988 and were followed through on June 1, 2004. A total of 515 women developed medical record-confirmed invasive endometrial cancer. We used Cox regression models to calculate multivariate relative risks (MVRRs), controlling for endometrial cancer risk factors. Women who worked 20+ years of rotating night shifts had a significantly increased risk of endometrial cancer [MVRR, 1.47; 95% confidence interval (95% CI), 1.03-1.14]. In stratified analyses, obese women working rotating night shifts doubled their baseline risk of endometrial cancer (MVRR, 2.09; 95% CI, 1.24-3.52) compared with obese women who did no night work, whereas a nonsignificant increase was seen among non-obese women (MVRR, 1.07; 95% CI, 0.60-1.92). Women working rotating night shifts for a long duration have a significantly increased risk of endometrial cancer, particularly if they are obese. We speculate that this increased risk is attributable to the effects of melatonin on hormonal and metabolic factors. Our results add to growing literature that suggests women who work at night may benefit from cancer prevention strategies.
引用
收藏
页码:10618 / 10622
页数:5
相关论文
共 29 条
[1]   Appetite regulation and seasonality: implications for obesity [J].
Adam, CL ;
Mercer, JG .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (03) :413-419
[2]   Melatonin enhances leptin expression by rat adipocytes in the presence of insulin [J].
Alonso-Vale, MIC ;
Andreotti, S ;
Peres, SB ;
Anhê, GF ;
Borges-Silva, CD ;
Neto, JC ;
Lima, FB .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (04) :E805-E812
[3]   Light/dark cycle-dependent metabolic changes in adipose tissue of pinealectomized rats [J].
Alonso-Vale, MIC ;
Borges-Silva, CN ;
Anhê, GF ;
Andreotti, S ;
Machado, MA ;
Cipolla-Neto, J ;
Lima, FB .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) :474-479
[4]  
Barrenetxe J, 2004, J PHYSIOL BIOCHEM, V60, P61, DOI 10.1007/BF03168221
[5]  
Blask David E., 2002, Current Topics in Medicinal Chemistry, V2, P113, DOI 10.2174/1568026023394407
[6]   Melatonin, sleep, and shift work adaptation [J].
Burch, JB ;
Yost, MG ;
Johnson, W ;
Allen, E .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2005, 47 (09) :893-901
[7]   The Nurses' Health Study: 20-year contribution to the understanding of health among women [J].
Colditz, GA ;
Manson, JE ;
Hankinson, SE .
JOURNAL OF WOMENS HEALTH, 1997, 6 (01) :49-62
[8]   Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity [J].
Cos, S ;
González, A ;
Güezmes, A ;
Mediavilla, MD ;
Martínez-Campa, C ;
Alonso-González, C ;
Sánchez-Barceló, EJ .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (02) :274-278
[9]   Melatonin modulates aromatase activity in MCF-7 human breast cancer cells [J].
Cos, S ;
Martínez-Campa, C ;
Mediavilla, MD ;
Sánchez-Barceló, EJ .
JOURNAL OF PINEAL RESEARCH, 2005, 38 (02) :136-142
[10]   Melatonin, an endogenous-specific inhibitor of estrogen receptor α via calmodulin [J].
del Río, B ;
Pedrero, JMG ;
Martínez-Campa, C ;
Zuazua, P ;
Lazo, PS ;
Ramos, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38294-38302